期刊文献+

土拉弗氏菌病患者血清抗体20年变化趋势分析 被引量:3

Analysis on alternation trend of antibodies in tularemia patients from 1985 to 2005
下载PDF
导出
摘要 目的了解土拉弗氏菌病患者免疫力维持时间、影响因素及一般人群中隐性感染情况。方法分别于发病后3周,6个月,2,3,6,7,8,9,20年采集血清,对山东省胶南县原外贸冷藏厂的31名土拉弗氏菌病患者及同地区一般人群进行纵向队列研究,检测血清中土拉弗氏菌特异性抗体,当效价>1∶40时为阳性;并于2005年对其发病状况和行为习惯等进行回顾性调查。结果病例组抗体几何平均滴度(GMT)从1986年的11890.00逐年下降到2005年的46.94,抗体效价衰减率为59.1%。早期抗体水平与后期抗体水平相关分析系数r=0.659(P<0.05),二者呈正相关。问卷调查表明,发病状况和行为习惯等与后期抗体水平的差异无统计学意义(P>0.05)。对照组历年来均为阴性。结论部分患者血清的土拉弗氏菌特异性抗体可长期存在,并呈逐渐下降趋势,而且后期抗体水平很大程度上受早期抗体效价高低的影响,与其他因素无关。一般人群无隐性感染。 ObJective To study the maintainable time of humoral immunity against Francisella tularensls after irdection, influence factors and the recessive infection situation in healthy people. Methods Thirty - one subjects with acute tularemia and the same area healthy people were studied for antibodies to Francisella tularensis by using Immuno - Chromatographic Assay(ICA) in third week(Jan., 1986), sixth month(July, 1986), second year(1987), third years(1988), sixth year(1991), seventh year(1992), eighth year(1993), ninth year(1994), twentieth year(2005). Special antibody were detected in the cohort study. Titers of 〉 1 : 40 were defined as positive . And the subjects were retrospectively studied in 2005. Resuits The GMT of subjects decreased from 11890.00 ( in 1986) to 46.94( in 2005). The rate of decay was 59.1%. A correlation was known between the titer of earlier period and that of the late - phase( r = 0. 659, P 〈 0.05). There were no statistically significant difference between the content of questionnaire and the late - phase titer. The control group was negative result during 20 years. Conclusion Special antibody in partial patients can last for a long time with a gradual reducing trend . The titer of the earlier period influence significantly that of the late - phase without other factors. And there is no recessive infection in the healthy people.
出处 《中国公共卫生》 CAS CSCD 北大核心 2006年第10期1201-1202,共2页 Chinese Journal of Public Health
关键词 土拉弗氏菌病 抗体 免疫力 Frenclsella tularensis antibody immunity
  • 相关文献

参考文献8

  • 1T(a)rnvik A,Berglund L.Tularemia[J].Eur Respir J,2003,21:361-373.
  • 2Rior RG,Klasson L,Larsson P,et al.Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4[J].J Appl Microbiol,2001,91:1-7.
  • 3Karlsson J,Prior RG,Williams K,et al.Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways,targets for the construction of a rationally attenuated auxotrophic vaccine[J].Microbiol Comp Gen,2000,5:25-39.
  • 4逢增昌 耿玉利 肖永泰.山东半岛首次土拉弗氏菌病爆发流行调查报告[J].中华流行病学杂志,1987,8(6):261-263.
  • 5端青,赵忠利,田青,张国珍.土拉菌单克隆抗体的制备及其特性的研究[J].中国人兽共患病杂志,2000,16(2):3-4. 被引量:6
  • 6Bevanger L,Maeland JA,Kvam AI.Comparative analysis of antibodies to francisella tularensis antigens during the acute phase of tularemia and eight years later[J].Clin Diagn Lab Immunol,1994,1 (2):238-240.
  • 7Koskela P,Salminen A.Humoral immunity against Francisella tularensis after natural infection[J].J Clin Microbiol,1985,22:973-979.
  • 8Ericsson M,Sandstrom G,Sjostedt A,et al.Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection[J].J Infect Dis,1994,170(1):110-114.

二级参考文献3

  • 1[1]Bogard W, D L Dunn and K Abemethy. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity [J].Infect Immun, 1987, 55: 899-908.
  • 2[2]Roy T, D Fleming snd W H Anderson. Tularemic pneumonia mimicking Legionnaires disease with false positive direct fluorescent antibodystains for legionella [J]. South Med J, 1989, 82: 1429-1431.
  • 3[3]Mark J Fulop, T Webber and Richard J. Production snd characterization of monoclonal antibodies directed against the lipopolysaccharide of Francisella tularensis [J].J of Clinical Microbiology, 1991, 29 (7): 1407-1412.

共引文献7

同被引文献42

  • 1McLendon M K, Apicella M A, Allen L AH. Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare [J]. Annu Rev Microbiol, 2006, 60:167-185.
  • 2Chu M C, Weyant R S, Murray P R, et al. Manual of Clinical Microbiology [M]. 8th. Washington DC: American Society for Microbiology, 2003:789-808.
  • 3Magnarelli L, Levy S, Koski R. Detetion of antibodies to Francisella tularensis in cats [J]. Res Vet Sci, 2007, 82(1):22-26.
  • 4Tarnvik A, Berglund L. Tularemia [J]. Eur Respir J, 2003, 21 (2): 361-373.
  • 5Porsch-Ozcurumez M, Kischel N, Priebe H, et al. Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for sero- logical diagnosis oftularaemia [J]. Clin Vaccine Immunol, 2004, 11(6): 1001-1015.
  • 6Aronova N V, Pavlovich N V. The use if lipopolysaccharide in the dot solid phase enzyme immunoassay [J]. Zh Mikrobiol Epidemiol Immunobiol, 2000, 5:75-78.
  • 7Berdal B P, Mehl R, Haaheim H, et al. Field detection of Francisella tularensis [J]. Scand J Infect Dis, 2000, 32(3): 287-291.
  • 8Bossi P, Tegnell A ,Baka A, et al. Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularemia [J]. Euro Surveill, 2004, 9(12): E9-E10.
  • 9Zhang F, Liu W, Wu X M, et al. Detection ofFrancisella tularensis in ticks and identification of their genotypes using multiple-locus variable-number tandem repeat analysis [J]. BMC Microbiology, 2008, 8( 152): 1-5.
  • 10Fujita O, Tatsumi M, Tanabayash K, et al. Development of a Real-Time PCR Assay for Detection and Quantification of Franciselle tularensis [J]. Jpn J Infect Dis, 2006(59): 46-51.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部